XML 50 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Significant Accounting Policies (Tables)
3 Months Ended 10 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2021
Schedule of calculation of basic and diluted net income (loss) per ordinary share The following table sets forth the calculation of basic and diluted earnings per share for the periods indicated based on the weighted average number of common shares outstanding:
    
Three Months Ended March 31,
 
    
2022
    
2021
 
Numerator
                 
Net loss available to Class A Unit holders
   $ (67,486    $ (11,609
Denominator
                 
Weighted average Class A Units outstanding, basic and diluted
     186,500,000        122,111,111  
Net loss per Class A Unit
                 
Net loss per Class A Unit, basic and diluted
   $ (0.36    $ (0.10
  The following table sets forth the calculation of basic and diluted earnings per share for the periods indicated based on the weighted average number of common shares outstanding:
    
Years Ended December 31,
 
    
2021
    
2020
 
Numerator
                 
Net loss available to Class A Unit holders
   $ (55,146    $ (26,749
Denominator
                 
Weighted average Class A Units outstanding, basic and diluted
     150,706,849        104,986,301  
Net loss per Class A Unit
                 
Net loss per Class A Unit, basic and diluted
   $ (0.37    $ (0.25
Schedule of accrued expenses
Accrued expenses as presented in the Condensed Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021 consisted of the following (in thousands):
 
    
March 31,
2022
    
December 31,
2021
 
Compensation
   $ 818      $ 1,832  
Clinical study related costs
     653        2,031  
Accrued legal
     3,095        964  
Manufacturing improvement costs
     3,137        4,164  
Other accrued expenses
     414        222  
    
 
 
    
 
 
 
Total accrued expenses and other
   $ 8,117      $ 9,213  
    
 
 
    
 
 
 
 
Accrued expenses which have been presented on the consolidated balance sheets as of December 31, 2021 and 2020 consisted of the following (in thousands):
 
    
December 31,
2021
    
December 31,
2020
 
Compensation
   $ 1,832      $ 1,085  
Clinical study related costs
     2,031        1,154  
Facility expansion costs
     19        1,709  
Accrued legal
     964        —    
Manufacturing improvement costs
     4,164        —    
Other accrued expenses
     203        548  
    
 
 
    
 
 
 
Total accrued expenses and other
   $ 9,213      $ 4,496  
    
 
 
    
 
 
 
Schedule of estimated useful lives The estimated useful lives are as follows:
 
Computer equipment and software
  
3-5
years
Furniture and equipment
  
5-7
years
Leasehold improvements
   remainder of lease term
  The estimated useful lives are as follows:
 
Computer equipment and software
  
3-
5
years
Furniture and equipment
  
5-
7
years
Leasehold improvements
   remainder of lease term
Schedule of fixed assets
Fixed assets consisted of the following (in thousands):
 
    
March 31,
2022
    
December 31,
2021
 
Furniture and equipment
   $ 2,220      $ 2,180  
Computer equipment and software
     589        569  
Leasehold improvements
     10,520        10,517  
Construction in progress
     631        351  
Less: accumulated depreciation
     (2,857      (2,259
    
 
 
    
 
 
 
Total fixed assets, net
   $ 11,103      $ 11,358  
    
 
 
    
 
 
 
 
Fixed assets consisted of the following (in thousands):
 
    
December 31,
2021
    
December 31,
2020
 
Furniture and equipment
   $ 2,180      $ 2,011  
Computer equipment and software
     569        130  
Leasehold improvements
     10,517        76  
Construction in progress
     351        7,854  
Less: accumulated depreciation
     (2,259      (1,157
    
 
 
    
 
 
 
Total fixed assets, net
   $ 11,358      $ 8,914  
    
 
 
    
 
 
 
Schedule of intangible asset The following table summarizes information related to the Company’s assembled workforce intangible asset (in thousands):
    
March 31,
2022
    
December 31,
2021
 
Gross carrying amount
   $ 1,073      $ 1,073  
Accumulated amortization
     699        645  
    
 
 
    
 
 
 
Net carrying amount
   $ 374      $ 428  
    
 
 
    
 
 
 
  The following table summarizes information related to the Company’s assembled workforce intangible asset (in thousands):
 
    
December 31,
2021
    
December 31,
2020
 
Gross carrying amount
   $ 1,073      $ 1,073  
Accumulated amortization
     645        431  
    
 
 
    
 
 
 
Net carrying amount
   $ 428      $ 642  
    
 
 
    
 
 
 
Social Capital Suvretta Holdings Corp. III [Member]      
Schedule of calculation of basic and diluted net income (loss) per ordinary share
At March 31, 2022 and December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following
table:
 
Gross proceeds
   $ 250,000,000  
Less:
        
Class A ordinary shares issuance costs
     (12,479,666 )
Plus:
        
Accretion of carrying value to redemption value
     12,487,990  
    
 
 
 
Class A ordinary shares subject to possible redemption, December 31,
2021
  
 
250,008,324
 

 
 
 
 
Plus:
        
Remeasurement of carrying value to redemption value
     (8,324 )
    
 
 
 
Class A ordinary shares subject to possible redemption, March 31, 2022
  
$
250,000,000
 

 
 
 
 
    
 
 
 
At December 31, 2021, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:
 

Gross proceeds
   $ 250,000,000  
Less:
        
Class A ordinary shares issuance costs
     (12,479,666
Plus:
        
Increase of carrying value to redemption value
     12,487,990  
    
 
 
 
Class A ordinary shares subject to possible redemption
  
$
250,008,324
 
    
 
 
 
 
Schedule of Class A Ordinary shares reflected in the Balance Sheets
The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):
 
 
  
For the

Three Months Ended
March 31, 2022
 
 
For the Period from
February 25, 2021
(Inception) Through

March 31, 2021
 
 
  
Class A
 
 
Class B
 
 
Class A
 
  
Class B
 
Basic and diluted net loss per ordinary share
  
     
 
     
 
     
  
     
Numerator:
  
     
 
     
 
     
  
     
Allocation of net loss
   $ (3,200,799    $ (780,226    $ —        $ (5,182
Denominator:
                                   
Basic and diluted weighted average shares outstanding
     25,640,000        6,250,000        —          5,500,000  
Basic and diluted net loss per ordinary share
   $ (0.12    $ (0.12    $ —        $ (0.00
The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts):
 
 
  
For the Period from

February 25, 2021 (Inception)
Through December 31, 2021
 
 
  
Class A
 
  
Class B
 
Basic and diluted net loss per ordinary share
  
     
  
     
Numerator:
  
     
  
     
Allocation of net loss
 
$
(1,675,346
)

 
$

(649,283
)

Denominator:
 
    
 
  
 
 
 
Basic and diluted weighted average shares outstanding
 
   15,101,877
 
  
 
5,852,751
 
 
 
  
 
 
  
 
 
 
Basic and diluted net loss per ordinary share
 
$

(0.11
)

  
$

(0.11
)